Terumo Corporation (TSE:4543) — MicroVention's parent company since 2006 — is a global leader in medical technology that has committed to “Contributing to Society through Healthcare” for nearly 100 years. Based in Tokyo with global operations, Terumo provides innovative medical solutions to over 160 countries. Their extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products that are essential for daily clinical practice. They pursue quality in all they do, from product excellence to customer care, in order to give our patients a better tomorrow.
Founded in 1921 with over 20,000 employees worldwide, Terumo has three main business areas: Cardiac and Vascular Company, General Hospital Company, and Blood Management Company; with MicroVention falling under the Neurovascular Division of the Cardiac and Vascular Company.
To learn the full story of Terumo since its foundation, please enjoy their book here: Terumo, A Century of Endeavor
To learn more about Terumo Corporation please visit their website, https://www.terumo.com/
Please note that MicroVention, Inc. does not control the information presented on these websites and that each of these websites may have their own Privacy Policies and other Notices and Disclaimers.